| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 59400 |
Routine obstetric care including antepartum care, vaginal delivery, and postpartum care |
727 |
652 |
$971K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,776 |
4,129 |
$423K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,089 |
4,218 |
$382K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,453 |
5,291 |
$371K |
| 76830 |
Ultrasound, transvaginal |
4,195 |
3,724 |
$299K |
| 59510 |
|
197 |
163 |
$275K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,226 |
1,195 |
$233K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
150 |
137 |
$127K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
117 |
104 |
$99K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
840 |
804 |
$90K |
| 76813 |
|
835 |
810 |
$83K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
995 |
947 |
$80K |
| 99215 |
Prolong outpt/office vis |
629 |
569 |
$71K |
| 87660 |
|
3,815 |
3,504 |
$68K |
| 87480 |
|
3,815 |
3,501 |
$68K |
| 87510 |
|
3,810 |
3,497 |
$67K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,284 |
2,039 |
$67K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,281 |
2,037 |
$67K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
995 |
930 |
$63K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
426 |
400 |
$56K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
731 |
583 |
$55K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
924 |
850 |
$55K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
566 |
370 |
$46K |
| 90715 |
|
905 |
873 |
$39K |
| 36415 |
Collection of venous blood by venipuncture |
15,935 |
13,975 |
$37K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,118 |
1,970 |
$37K |
| 81002 |
|
12,073 |
9,012 |
$37K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
483 |
375 |
$35K |
| 99205 |
Prolong outpt/office vis |
204 |
187 |
$33K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
485 |
361 |
$32K |
| 59426 |
|
63 |
58 |
$31K |
| 59025 |
Fetal non-stress test |
762 |
439 |
$27K |
| 58301 |
|
247 |
217 |
$23K |
| J7297 |
Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
33 |
27 |
$22K |
| 58300 |
|
366 |
327 |
$17K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
217 |
119 |
$16K |
| 59425 |
|
63 |
52 |
$16K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
323 |
281 |
$15K |
| 81025 |
|
1,907 |
1,670 |
$14K |
| 90674 |
|
575 |
528 |
$11K |
| 93976 |
|
73 |
64 |
$11K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
194 |
173 |
$10K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
355 |
318 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
767 |
586 |
$9K |
| 11981 |
|
68 |
62 |
$9K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
800 |
705 |
$7K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
73 |
59 |
$5K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
239 |
165 |
$5K |
| 85018 |
|
2,232 |
1,872 |
$4K |
| 99000 |
|
9,253 |
7,202 |
$4K |
| A4550 |
Surgical trays |
781 |
693 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
212 |
171 |
$3K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
64 |
62 |
$2K |
| 86769 |
|
60 |
34 |
$2K |
| 36410 |
|
304 |
246 |
$2K |
| 99385 |
|
16 |
12 |
$1K |
| 90686 |
|
67 |
63 |
$1K |
| 99072 |
|
5,642 |
4,131 |
$561.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
17 |
12 |
$516.78 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
19 |
19 |
$212.61 |
| 36416 |
|
17 |
12 |
$0.00 |